Related Experiment Videos
Concentration-dependent clearance of procainamide in normal subjects
Biopharmaceutics & Drug Disposition
|April 1, 1985
Summary
This study found that higher doses of PA (perampanel) led to concentration-dependent decreases in its clearance in healthy volunteers. These changes in perampanel clearance may be clinically significant.
Area of Science:
- Pharmacokinetics
- Drug Metabolism
- Clinical Pharmacology
Background:
- Understanding drug clearance is crucial for optimizing therapeutic efficacy and safety.
- Perampanel (PA) is an antiepileptic drug whose pharmacokinetic profile requires thorough investigation.
Purpose of the Study:
- To investigate the dose-dependency of perampanel (PA) pharmacokinetics in healthy subjects.
- To determine if PA clearance is concentration-dependent at therapeutic levels.
Main Methods:
- Four healthy volunteers received two intravenous doses of PA (low and high).
- Blood and urine samples were collected over 12 and 48 hours, respectively.
- PA concentrations were quantified using High-Performance Liquid Chromatography (HPLC).
Main Results:
- Higher PA doses resulted in concentration-dependent decreases in nonrenal and total clearance.
- Nonrenal PA clearance decreased by 31-43% and total clearance by 4.7-36% (p<0.05).
- No significant dose-related differences were observed in renal clearance, elimination rate, or volume of distribution.
Conclusions:
- Perampanel (PA) clearance is concentration-dependent in normal subjects at therapeutic plasma concentrations.
- The observed changes in total clearance suggest potential clinical importance for perampanel dosing.
- Further research is warranted to explore the clinical implications of PA concentration-dependent clearance.